About SAMBA BIOLOGICS INC.
Samba BioLogics is a preclinical stage biotechnology company based in Vermont, developing breakthrough agonist biologics to preserve tissue and improve repair after ischemic injury. Their pipeline includes Cell-Kro and VasaPlex, which aim to promote engraftment of transplanted progenitor cells and rescue cardiac tissue after myocardial infarction.
Is this your company?
Claim SAMBA BIOLOGICS INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim SAMBA BIOLOGICS INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.